Related references
Note: Only part of the references are listed.Reduced Vancomycin Susceptibility in Staphylococcus aureus, Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications
Benjamin P. Howden et al.
CLINICAL MICROBIOLOGY REVIEWS (2010)
Vancomycin Therapeutic Guidelines: A Summary of Consensus Recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists
Michael J. Rybak et al.
CLINICAL INFECTIOUS DISEASES (2009)
Evaluation of the Etest GRD for the detection of Staphylococcus aureus with reduced susceptibility to glycopeptides
Steven N. Leonard et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Accuracy of Commercial and Reference Susceptibility Testing Methods for Detecting Vancomycin-Intermediate Staphylococcus aureus
Jana M. Swenson et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Vancomycin MIC plus Heteroresistance and Outcome of Methicillin-Resistant Staphylococcus aureus Bacteremia: Trends over 11 Years
Adina C. Musta et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Clinical Features of Heteroresistant Vancomycin-Intermediate Staphylococcus aureus Bacteremia versus Those of Methicillin-Resistant S. aureus Bacteremia
Yasmin Maor et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Persistent Staphylococcus aureus bacteremia: Incidence and outcome trends over time
Riad Khatib et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2009)
Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin
T. P. Lodise et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia
Alex Soriano et al.
CLINICAL INFECTIOUS DISEASES (2008)
Heteroresistance: a concern of increasing clinical significance?
M. E. Falagas et al.
CLINICAL MICROBIOLOGY AND INFECTION (2008)
Evaluation of a new etest vancomycin-teicoplanin strip for detection of glycopeptide-intermediate Staphylococcus aureus (GISA), in particular, heterogeneous GISA
Anne Yusof et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Characterization of vancomycin-heteroresistant Staphylococcus aureus from the metropolitan area of Detroit, Michigan, over a 22-year period (1986 to 2007)
Michael J. Rybak et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2008)
Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia
Pamela A. Moise et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Heterogeneous resistance to vancomycin and teicoplanin among Staphylococcus spp. isolated from bacteremia
Ana Paula Ferreira Nunes et al.
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES (2007)
Hetero-vancomycin-intermediate methicillin-resistant Staphylococcus aureus isolate from a medical center in Las Cruces, New Mexico
Alejandro Delgado et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period
Guiqing Wang et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
A 1 year surveillance study of glycopeptide-intermediate Staphylococcus aureus strains in a French hospital
F Garnier et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Management of persistent Bacteremia caused by methicillin-resistant Staphylococcus aureus: A survey of infectious diseases consultants
Jeffrey C. Hageman et al.
CLINICAL INFECTIOUS DISEASES (2006)
Recognition and management of infections caused by vancomycin-intermediate Staphylococcus aureus (VISA) and heterogenous VISA (hVISA)
BP Howden
INTERNAL MEDICINE JOURNAL (2005)
Novel multiplex PCR assay for characterization and concomitant subtyping of staphylococcal cassette chromosome mec types I to V in methicillin-resistant Staphylococcus aureus
KY Zhang et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Methicillin-resistant Staphylococcus aureus heterogeneously resistant to vancomycin in a Turkish university hospital
B Sancak et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Time to positivity in Staphylococcus aureus bacteremia:: Possible correlation with the source and outcome of infection
R Khatib et al.
CLINICAL INFECTIOUS DISEASES (2005)
Treatment outcomes for serious infections caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility
BP Howden et al.
CLINICAL INFECTIOUS DISEASES (2004)
Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia
G Sakoulas et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Evidence for a continuum of decreased vancomycin susceptibility in unselected Staphylococcus aureus clinical isolates
FM Hussain et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital
M Wootton et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
Share Paper
